DE2611041C2 - - Google Patents
Info
- Publication number
- DE2611041C2 DE2611041C2 DE2611041A DE2611041A DE2611041C2 DE 2611041 C2 DE2611041 C2 DE 2611041C2 DE 2611041 A DE2611041 A DE 2611041A DE 2611041 A DE2611041 A DE 2611041A DE 2611041 C2 DE2611041 C2 DE 2611041C2
- Authority
- DE
- Germany
- Prior art keywords
- weight
- formulation
- release
- pharmaceutical
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55910775A | 1975-03-17 | 1975-03-17 | |
US65800376A | 1976-02-13 | 1976-02-13 | |
KR7600645A KR800001387B1 (en) | 1975-03-17 | 1976-03-16 | Process for preparing sustained release formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2611041A1 DE2611041A1 (de) | 1976-10-14 |
DE2611041C2 true DE2611041C2 (US20080094685A1-20080424-C00004.png) | 1988-06-09 |
Family
ID=27348140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762611041 Granted DE2611041A1 (de) | 1975-03-17 | 1976-03-16 | Retard-formulierung |
Country Status (21)
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
CH649215A5 (de) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | Pharmazeutische praeparate. |
CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
CH666406A5 (de) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. |
KR850700212A (ko) * | 1984-03-21 | 1985-12-26 | 죠지 드모트 | 서방성 약제학적 캼셀제 |
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
HU195729B (en) * | 1985-02-05 | 1988-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides |
GB8524135D0 (en) * | 1985-10-01 | 1985-11-06 | Sandoz Ltd | Darodipine compositions |
HU197201B (en) * | 1985-10-01 | 1989-03-28 | Sandoz Ag | Process for producing oral pharmaceutical compositions of controlled solubility of the active components |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
ES2089498T3 (es) * | 1991-01-30 | 1996-10-01 | Wellcome Found | Comprimidos dispersables en agua. |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
WO1992017166A1 (en) * | 1991-04-08 | 1992-10-15 | Nippon Shinyaku Co., Ltd. | Capsule |
DK0632720T3 (da) * | 1992-03-25 | 1999-07-26 | Depomed Inc | Hydroxyethylcellulosebaserede depotpræparat-doseringsformer |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
CN1133558A (zh) * | 1993-10-29 | 1996-10-16 | 雷克特和科尔曼产品有限公司 | 可发泡的明胶胶囊填充药物 |
EP0725625B1 (en) * | 1993-10-29 | 2000-03-22 | R.P. Scherer Corporation | Gelatin capsule fill able to foam |
US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
CA2190188A1 (en) * | 1994-05-13 | 1995-11-23 | Prasad S. Adusumilli | Method and composition for increasing calcium uptake |
WO1996016638A1 (en) * | 1994-12-01 | 1996-06-06 | Cibus Pharmaceutical, Inc. | Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants |
FR2820318B1 (fr) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu |
FR2820319B3 (fr) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu |
EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
FR2874325B1 (fr) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1059624B (de) * | 1954-11-11 | 1959-06-18 | Dr Knut Jacobus Sundman | Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form |
JPS5512411B2 (US20080094685A1-20080424-C00004.png) * | 1974-03-12 | 1980-04-02 | ||
DE2439538C3 (de) * | 1974-08-17 | 1980-07-17 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe |
-
1976
- 1976-03-05 CH CH277676A patent/CH630257A5/de not_active IP Right Cessation
- 1976-03-11 IE IE508/76A patent/IE43083B1/en unknown
- 1976-03-15 GR GR50306A patent/GR60341B/el unknown
- 1976-03-15 NZ NZ180321A patent/NZ180321A/xx unknown
- 1976-03-15 MC MC761182A patent/MC1101A1/xx unknown
- 1976-03-15 LU LU74558A patent/LU74558A1/xx unknown
- 1976-03-15 FR FR7607363A patent/FR2304354A1/fr active Granted
- 1976-03-16 DE DE19762611041 patent/DE2611041A1/de active Granted
- 1976-03-16 PT PT64907A patent/PT64907B/pt unknown
- 1976-03-16 CA CA248,018A patent/CA1073358A/en not_active Expired
- 1976-03-16 ES ES446075A patent/ES446075A1/es not_active Expired
- 1976-03-16 GB GB10482/76A patent/GB1546448A/en not_active Expired
- 1976-03-16 DD DD191877A patent/DD124102A5/xx unknown
- 1976-03-16 SE SE7603325A patent/SE433804B/xx not_active IP Right Cessation
- 1976-03-16 AT AT192276A patent/AT353415B/de not_active IP Right Cessation
- 1976-03-16 DK DK113676A patent/DK148344C/da not_active IP Right Cessation
- 1976-03-16 JP JP51027758A patent/JPS51115910A/ja active Granted
- 1976-03-16 AU AU12049/76A patent/AU505355B2/en not_active Expired
- 1976-03-17 NL NLAANVRAGE7602776,A patent/NL190313C/xx not_active IP Right Cessation
- 1976-03-17 AR AR262597A patent/AR222624A1/es active
- 1976-03-29 PH PH18224A patent/PH14927A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2611041C2 (US20080094685A1-20080424-C00004.png) | ||
DE69821553T2 (de) | Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat | |
DE69022876T2 (de) | Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe. | |
EP0068191B1 (de) | Orale Dipyridamolformen | |
DE69624907T3 (de) | Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten | |
AT398165B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung | |
DE3811114C2 (de) | Zweischichtige Dosierungsform zur Abgabe eines Wirkstoffs | |
DE69629797T2 (de) | Matrix zur gesteuerten freisetzung von arzneistoffen | |
DE3780222T2 (de) | Pharmazeutische zusammensetzung mit kontrollierter wirkstofffreisetzung. | |
US4140755A (en) | Sustained release tablet formulations | |
DE1617374C2 (de) | Verfahren zum Herstellen eines pharmazeutischen Präparates mit verzögerter analgetischer Wirkung | |
US4167558A (en) | Novel sustained release tablet formulations | |
DE2808514A1 (de) | Nitrofurantoin enthaltende tablette | |
EP0272265B1 (de) | Zerfallstablette und verfahren zu ihrer herstellung | |
DE69820287T2 (de) | Pharmazeutische Zubereitung, die Chlodronat als Wirkstoff und silicifizierte mikrokristalline Cellulose als Exipienten umfasst | |
DE69233239T2 (de) | Pharmazeutische Granulate mit intragranularem Sprengmittel | |
DE68904459T2 (de) | Antacidzusammensetzungen mit laengerer verweilzeit im magen. | |
EP0486863B1 (de) | Antazida-Zubereitung mit verlängerter Magenverweilzeit | |
DE69009684T2 (de) | Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen. | |
AT398166B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen) | |
DE68903605T2 (de) | Kautablette. | |
DE69815856T2 (de) | Cefadroxilmonohydrat tablettenformulierung | |
EP0108898A1 (de) | Neue orale Mopidamolformen | |
DE69814850T2 (de) | Paracetamol enthaltende schlickbare tablette | |
EP0250648B1 (de) | Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH |
|
8328 | Change in the person/name/address of the agent |
Free format text: LEDERER, F., DIPL.-CHEM. DR., 8000 MUENCHEN RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING., PAT.-ANWAELTE, 8300 LANDSHUT |